Kymo Therapeutics
Kymo Therapeutics has a goal to advance Metabrain’s kynurenine metabolism (KMO) inhibitors towards clinical proof of concept.
Listed
Biotechnology in the same market
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Kymo Therapeutics in front of investors. Or tell us what we have wrong.